Showing results (1541-1550 of 2,063) with videos related to

Sort By:
Pageof 207
Brachytherapy|May 16, 2016
Prospective study of direct radiation exposure measurements for family members living with patients with prostate (125)I seed implantation: Evidence of radiation safetyTakashi Hanada, Atsunori Yorozu, Yukiko Shinya, et al.
Brachytherapy|April 20, 2016
CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspectsR A Nout, S Devic, T Niazi, et al.
Brachytherapy|February 26, 2025
HDR brachytherapy salvage for nodular prostate fossa recurrence: A mechanistic review and initial report of clinical outcomesLauren M Andring, Rebecca F Krc, Elleana Paradise, et al.
Brachytherapy|January 31, 2025
3D-printed radiopaque episcleral plaques with radioactive collimating cavities for enhanced dose delivery in brachytherapySouheib Zekraoui, Théophraste Lescot, Mahdokht Akbari Taemeh, et al.
Brachytherapy|February 15, 2025
3D-printed needle guides for cervical cancer brachytherapy: Optimized dosimetry and improved local control outcomesSantino Butler, Thomas Niedermayr, Elizabeth A Kidd
Brachytherapy|January 16, 2025
Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective studyBharath Kumar, Prachi Mittal, Ankita Gupta, et al.
Brachytherapy|January 4, 2025
Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrencesComron Hassanzadeh, Osama Mohamad, Teresa Bruno, et al.
Brachytherapy|January 8, 2025
The influence of time and implants in high-dose rate image-guided adaptive brachytherapy for locally advanced cervical cancerLeonel Varela Cagetti, Laurence Gonzague-Casabianca, Marjorie Ferré, et al.
Brachytherapy|December 10, 2024
Complications of intravascular brachytherapyKent Wallner, Kathleen E Kearney, Lorenzo Azzalini, et al.
Brachytherapy|December 14, 2024
High-dose-rate (2 fractions of 13.5 Gy) and low-dose-rate brachytherapy as monotherapy in prostate cancer. Long term outcomes and predictive value of nadir prostate-specific antigenSilvia Rodríguez Villalba, Diana Guevara Barrera, Luis Suso-Martí, et al.
Pageof 207